CT-free thyroid SPECT study based on artificial intelligence

Multi-center Non-inferiority Clinical Trial for CT-free Quantitative Thyroid SPECT based on Artificial Intelligence

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0008387

Enrollment

152

Registered

2023-04-27

Start date

2023-04-13

Completion date

Unknown

Last updated

2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : CT-free SPECT implemented only with SPECT using artificial intelligence without CT in thyroid SPECT/CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Patients who are 19 years old or older. - Patients who are newly diagnosed with thyrotoxicosis, and show a decrease in thyroid stimulating hormone (TSH) while T3 or T4 levels are elevated or normal.

Exclusion criteria

Exclusion criteria: -History of diagnosis or treatment for hyperthyroidism or thyroiditis -History of taking antithyroid medications (propylthiouracil, methimazole, carbimazole) or thyroid hormones (thyroxine, triiodothyronine) -History of thyroidectomy -Coexisting thyroid cancer -Intra-thoracic goiter -Contrast-enhanced CT scan with iodine within 2 months -History of taking medications (such as lithium, amiodarone, immune-checkpoint inhibitors) that affect thyroid function -Technically not feasible for artificial intelligence operation

Design outcomes

Primary

Measure	Time frame
Diagnostic accuracy for Graves' disease	—

Secondary

Measure	Time frame
Diagnostic accuracy for destructive thyroiditis;Accuracy for predicting prescription of anti-thyroid medications	—

Countries

Korea, Republic of

Contacts

Public ContactWon Woo Lee

Seoul National University Bundang Hospital

wwlee@snubh.org+82-31-787-7672

Outcome results